KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Raw Materials (2016 - 2022)

Bio-Rad Laboratories (BIO) has disclosed Raw Materials for 14 consecutive years, with $188.5 million as the latest value for Q2 2022.

  • Quarterly Raw Materials rose 56.87% to $188.5 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $188.5 million through Jun 2022, up 56.87% year-over-year, with the annual reading at $116.9 million for FY2021, 7.9% down from the prior year.
  • Raw Materials for Q2 2022 was $188.5 million at Bio-Rad Laboratories, up from $146.2 million in the prior quarter.
  • The five-year high for Raw Materials was $188.5 million in Q2 2022, with the low at $104.0 million in Q1 2020.
  • Average Raw Materials over 5 years is $123.3 million, with a median of $118.3 million recorded in 2018.
  • The sharpest move saw Raw Materials decreased 18.41% in 2021, then skyrocketed 56.87% in 2022.
  • Over 5 years, Raw Materials stood at $108.0 million in 2018, then rose by 1.45% to $109.6 million in 2019, then rose by 15.83% to $126.9 million in 2020, then fell by 7.9% to $116.9 million in 2021, then soared by 61.26% to $188.5 million in 2022.
  • According to Business Quant data, Raw Materials over the past three periods came in at $188.5 million, $146.2 million, and $116.9 million for Q2 2022, Q1 2022, and Q4 2021 respectively.